Skip to content
AwardedCzechiaGoodsCZK 18,226,680

Dodávky léků – Léčivá látka bevacizumab - ATC L01FG01

Published
Published 27 January 2026
Deadline
Closed 27 February 2026

Overview

Fakultní Thomayerova nemocnice procured ongoing supplies of bevacizumab (active pharmaceutical ingredient, ATC L01FG01) in two formulations: 25mg/ml infusion concentrate solution in 16ml vials (4,500 units) and 4ml vials (3,500 units). The contract was awarded to PROMEDICA PRAHA GROUP, a.s. on 3 March 2026 for 8,730,690 CZK against an estimated value of 18,226,680 CZK.

Key details

Country
Czechia
Status
Awarded
Category
Goods
Estimated value
CZK 18,226,680
Procedure
Open
SME suitable
Yes
Published
27 January 2026
Deadline
Closed
Classification (CPV)
Antineoplastic agents

Award outcome

Awarded value
CZK 8,730,690
Award date
3 March 2026
Contract period
19 March 2026 → 26 February 2030
Winner
  • PROMEDICA PRAHA GROUP, a.s.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    23 March 2026

  2. Contract Notice

    27 January 2026

Contracting authority

  • Fakultní Thomayerova nemocnice

    Procuring entity

    Praha, Czechia

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Dodávky léků – Léčivá látka bevacizumab - ATC L01FG01 — won by PROMEDICA PRAHA GROUP, a.s. — Skim